Management of excessive tearing as a side effect of docetaxel.

Bita Esmaeli

Journal: Clinical breast cancer 2005;5(6):455-7

PMID: 15748466

Full Text on Elsevier Science View on PubMed

Abstract

Docetaxel is a highly effective chemotherapeutic agent for metastatic or locally advanced breast cancer as well as other malignancies. One of the side effects of weekly administration of docetaxel is epiphora (excessive tearing) caused by canalicular stenosis and nasolacrimal duct obstruction. This article summarizes experience with epiphora and canalicular stenosis as a side effect of docetaxel and provides specific recommendations for management of this side effect.

Address: Section of Ophthalmology, Department of Plastic Surgery, Unit 443, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. [email protected]

DOI: 10.3816/cbc.2005.n.004

Link outs

Free resources

Medical:

https://medlineplus.gov/tears.html

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

MeSH Terms: Antineoplastic Agents, Phytogenic, Breast Neoplasms, Conjunctivitis, Constriction, Pathologic, Docetaxel, Female, Humans, Lacrimal Apparatus Diseases, Taxoids